Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Details) - Schedule of stock option activities

v3.22.1
Shareholders' Deficit (Details) - Schedule of stock option activities - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Shareholders' Deficit (Details) - Schedule of stock option activities [Line Items]      
Number of Options, Balance Outstanding, Beginning   8,445,698 2,050,000
Weighted Average Exercise Price, Balance Outstanding, Beginning   $ 0.4 $ 0.1
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Beginning    
Aggregate Intrinsic Value, Balance Outstanding, Beginning    
Number of Options, Exercised    
Weighted Average Exercise Price, Exercised    
Weighted Average Remaining Contractual Term (Years), Exercised    
Aggregate Intrinsic Value, Exercised    
Number of Options, Balance Outstanding, Ending   8,445,698 2,050,000
Stock options [Member]      
Shareholders' Deficit (Details) - Schedule of stock option activities [Line Items]      
Number of Options, Balance Outstanding, Beginning 8,445,698 8,445,698  
Number of Options, Exercised    
Weighted Average Exercise Price, Exercised    
Weighted Average Remaining Contractual Term (Years), Exercised    
Aggregate Intrinsic Value, Exercised    
Number of Options, Balance Outstanding, Ending 8,445,698 8,445,698  
Weighted Average Exercise Price, Balance Outstanding, Ending $ 0.4 $ 0.4  
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending 4 years 1 month 6 days 5 years 1 month 6 days  
Aggregate Intrinsic Value, Balance Outstanding, Ending $ 0 $ 48,000  
Number of Options, Exercisable 8,445,698    
Weighted Average Exercise Price, Exercisable $ 0.4    
Weighted Average Remaining Contractual Term (Years), Exercisable, 4 years 1 month 6 days    
Aggregate Intrinsic Value, Exercisable $ 0